2018 update of the EULAR recommendations for the management of Behçet’s syndrome

Several new treatment modalities with different mechanisms of action have been studied in patients with Behçet’s syndrome (BS). The aim of the current effort was to update the recommendations in the light of these new data under the auspices of the European League Against Rheumatism (EULAR) Standing...

Full description

Saved in:
Bibliographic Details
Published in:Annals of the rheumatic diseases 2018-06, Vol.77 (6), p.808-818
Main Authors: Hatemi, Gulen, Christensen, Robin, Bang, Dongsik, Bodaghi, Bahram, Celik, Aykut Ferhat, Fortune, Farida, Gaudric, Julien, Gul, Ahmet, Kötter, Ina, Leccese, Pietro, Mahr, Alfred, Moots, Robert, Ozguler, Yesim, Richter, Jutta, Saadoun, David, Salvarani, Carlo, Scuderi, Francesco, Sfikakis, Petros P, Siva, Aksel, Stanford, Miles, Tugal-Tutkun, Ilknur, West, Richard, Yurdakul, Sebahattin, Olivieri, Ignazio, Yazici, Hasan
Format: Article
Language:English
Subjects:
anti-tnf
Arthritis
Behcet Syndrome - drug therapy
behcet’s disease
Disease management
Evidence-Based Medicine - methods
Experts
Gastroenterology
Gastrointestinal Diseases - drug therapy
Glucocorticoids - therapeutic use
Humans
Immunology
Immunosuppressive Agents - therapeutic use
Life Sciences
Literature reviews
Medical personnel
Nervous system
Nervous System Diseases - drug therapy
Patients
Physicians
Recommendation
Surgery
Systematic review
Task forces
treatment
Uveitis, Anterior - drug therapy
Vein & artery diseases
Venous Thrombosis - drug therapy
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!